On the afternoon of December 27, 2017, Li Yunlin, Deputy Director of the Education, Science, Culture, Health and Sports Committee of Zhejiang Provincial People's Congress, Xie Guoyi, Director of the Office of the Education, Science, Culture, Health and Sports Committee of the Provincial People's Congress, Qi Yongyuan, Deputy Director of Lishui Municipal People's Congress Standing Committee, Li Yangde, Director of the Education, Science, Culture, Health and Sports Department of the Municipal People's Congress, and other officials visited Zhejiang Benefit Pharmaceutical for research and guidance.

At the symposium, Zhang Liyun, Chief Administrative Officer, extended a warm welcome to the leaders for their research and guidance, and briefly introduced the situation of the four subsidiaries under the company.

Subsequently, Chairman Wu Lihua made a detailed report to Deputy Director Li and his entourage on the company's current situation, enterprise development strategic layout, and modern traditional Chinese medicine production, focusing on the implementation of the "traditional Chinese medicine formula granules" project.

After listening to the report, Deputy Director Li highly recognized the company's persistence in research and development and enterprise innovation, and looked forward to Benefit breaking through to a broader new world, integrating into the Belt and Road Initiative, and going global. Deputy Director Li pointed out that as the only pilot manufacturer of "traditional Chinese medicine formula granules" in Lishui, Zhejiang Benefit Pharmaceutical should seize the prerequisites, continuously expand new channels, integrate strategic thinking, integrate the construction of ecological civilization and green development in Lishui in the new era, and combine the construction ideas of Zhejiang Grand Garden. Taking advantage of Lishui's unique advantages, it should effectively and sustainably inherit and develop traditional Chinese medicine, and provide high-quality products to serve more people.